Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Cardiology

  • Home
  • Specialties
  • Cardiology
  • Page 12
Exploring the Link Between Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure Risk in Older Adults
Posted inCardiology Nephrology news

Exploring the Link Between Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure Risk in Older Adults

Posted by MedXY By MedXY 04/29/2026
Higher CKM syndrome stages correlate with adverse cardiac remodeling and increased heart failure risk in older adults, as shown in the ARIC Study.
Read More
Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes
Posted inCardiology Diabetes & Endocrinology news OB/GYN & Women's Health

Prolonged TSH Suppression in Postmenopausal Thyroid Cancer Patients Linked to Worse Cardiovascular and Quality-of-Life Outcomes

Posted by MedXY By MedXY 04/28/2026
Study finds long-term TSH suppression in postmenopausal women with thyroid cancer correlates with poorer cardiovascular health, reduced quality of life, and increased osteoporosis risk compared to controls.
Read More
Circulatory Support Escalation in Cardiogenic Shock: Outcomes and Predictors of Success
Posted inCardiology Critical Care news

Circulatory Support Escalation in Cardiogenic Shock: Outcomes and Predictors of Success

Posted by MedXY By MedXY 04/28/2026
A multi-center study reveals that circulatory support escalation in cardiogenic shock is associated with higher mortality and complications, but certain patient factors can predict successful outcomes.
Read More
RBM20 Truncating Variants in Dilated Cardiomyopathy: Reduced Penetrance and Milder Phenotype Compared to Missense Variants
Posted inCardiology news

RBM20 Truncating Variants in Dilated Cardiomyopathy: Reduced Penetrance and Milder Phenotype Compared to Missense Variants

Posted by MedXY By MedXY 04/28/2026
This study highlights the role of RBM20 truncating variants in arrhythmogenic dilated cardiomyopathy, showing reduced penetrance and milder disease severity compared to pathogenic missense variants and titin truncating variants.
Read More
Pre-Treatment Fibrin Clot Lysis Time Predicts Bleeding Risk in Atrial Fibrillation Patients on Oral Anticoagulants
Posted inCardiology news

Pre-Treatment Fibrin Clot Lysis Time Predicts Bleeding Risk in Atrial Fibrillation Patients on Oral Anticoagulants

Posted by MedXY By MedXY 04/28/2026
Shorter pre-treatment fibrin clot lysis time independently predicts higher bleeding risk in AF patients on oral anticoagulation, as evidenced by the ARISTOTLE trial.
Read More
Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions
Posted inCardiology news Public Health

Global Disparities in Heart Failure: Incidence and Mortality Across Income Levels and Regions

Posted by MedXY By MedXY 04/28/2026
The PURE study reveals significant global disparities in heart failure incidence and mortality, with hypertension as the leading modifiable risk factor, highlighting the need for targeted prevention and treatment strategies.
Read More
PRAETORIAN-DFT Trial Validates Omission of Defibrillation Testing in S-ICD Implantation
Posted inCardiology news

PRAETORIAN-DFT Trial Validates Omission of Defibrillation Testing in S-ICD Implantation

Posted by MedXY By MedXY 04/28/2026
The PRAETORIAN-DFT trial demonstrates that omitting defibrillation testing in subcutaneous ICD implantation, guided by the PRAETORIAN score, is non-inferior to traditional testing for first-shock efficacy, reducing procedural risks without compromising safety.
Read More
Early Resistance Training and Verticalization During ECMO: A Safe Path to Improved Functional Outcomes
Posted inCardiology Critical Care news

Early Resistance Training and Verticalization During ECMO: A Safe Path to Improved Functional Outcomes

Posted by MedXY By MedXY 04/28/2026
A structured exercise program combining mobility therapy and resistance training in ECMO patients proved feasible and safe, with longer session times correlating with better functional performance.
Read More
Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed
Posted inCardiology news

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

Posted by MedXY By MedXY 04/24/2026
A study finds bradykinin modestly contributes to blood pressure reduction with sacubitril/valsartan in chronic heart failure, highlighting ANP's role in initial effects and bradykinin's influence during chronic therapy.
Read More
Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity
Posted inCardiology Emergency Medicine news

Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity

Posted by MedXY By MedXY 04/24/2026
A novel sixth-gen hs-cTnT assay with a 13 ng/L threshold safely identified twice as many low-risk MI patients at ED presentation vs fifth-gen assays, achieving >99.5% NPV in multinational validation.
Read More
Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction
Posted inCardiology Hematology-Oncology news

Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction

Posted by MedXY By MedXY 04/24/2026
New research identifies P2Y14R as a key regulator of neutrophil-platelet aggregates and NET formation in venous thrombosis, with proglumide showing promise as a therapeutic antagonist.
Read More
Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients
Posted inCardiology news

Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients

Posted by MedXY By MedXY 04/24/2026
A randomized trial shows left bundle branch pacing significantly reduces the risk of pacing-induced cardiomyopathy and improves cardiac function compared to right ventricular pacing in high-risk patients.
Read More
Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy
Posted inCardiology news Pediatrics

Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy

Posted by MedXY By MedXY 04/24/2026
A multiregistry analysis reveals that massive LVH in pediatric HCM is linked to early diagnosis, sarcomeric mutations, and heightened risks of arrhythmias, heart failure, and mortality. Nearly 25% of patients show significant LVH regression over time.
Read More
LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED
Posted inCardiology Emergency Medicine news

LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED

Posted by MedXY By MedXY 04/24/2026
The LEGEND trial demonstrates that a high-sensitivity troponin-based rule-out strategy significantly reduces hospital length of stay and cardiac testing while safely excluding acute myocardial infarction in emergency department patients.
Read More
Fenestrated and Branched EVAR Shows Promise in Complex Aortic Aneurysms with 80% Survival at 5 Years
Posted inCardiology General Surgery news

Fenestrated and Branched EVAR Shows Promise in Complex Aortic Aneurysms with 80% Survival at 5 Years

Posted by MedXY By MedXY 04/23/2026
A high-volume aortic center study reveals 93.6% technical success and 82.6% survival at 60 months with f/bEVAR for complex aneurysms, though reinterventions remain frequent.
Read More
44% of Women with HDP Develop Chronic Hypertension Within 10 Years: Missed Opportunities in Postpartum Care
Posted inCardiology news

44% of Women with HDP Develop Chronic Hypertension Within 10 Years: Missed Opportunities in Postpartum Care

Posted by MedXY By MedXY 04/23/2026
A French cohort study reveals 44% of women receiving postpartum antihypertensives after HDP develop chronic hypertension within 10 years, signaling urgent gaps in long-term cardiovascular risk monitoring.
Read More
Right Ventricular to Pulmonary Artery Coupling: A New Prognostic Marker in Heart Failure Therapy
Posted inCardiology news

Right Ventricular to Pulmonary Artery Coupling: A New Prognostic Marker in Heart Failure Therapy

Posted by MedXY By MedXY 04/22/2026
A study reveals that RV-PA coupling, measured by TAPSE/sPAP ratio, significantly predicts outcomes in HFrEF patients during GDMT up-titration, highlighting its potential as a treatment target.
Read More
Biventricular Pacing Outperforms Conduction System Pacing in Heart Failure: Key Insights from PhysioSync-HF Trial
Posted inCardiology news

Biventricular Pacing Outperforms Conduction System Pacing in Heart Failure: Key Insights from PhysioSync-HF Trial

Posted by MedXY By MedXY 04/22/2026
PhysioSync-HF trial reveals CSP is inferior to BiVP for HFrEF patients with LBBB, challenging its role as a first-line resynchronization therapy despite cost benefits.
Read More
Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients
Posted inCardiology news Oncology

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients

Posted by MedXY By MedXY 04/22/2026
Elevated levels of inflammatory and cardiac biomarkers are linked to higher risks of venous thromboembolism and bleeding in cancer patients, according to a post hoc analysis of the AVERT trial.
Read More
Focal vs. Diffuse Coronary Artery Disease: How Disease Pattern Influences PCI’s Placebo-Controlled Symptom Relief in ORBITA-2
Posted inCardiology news

Focal vs. Diffuse Coronary Artery Disease: How Disease Pattern Influences PCI’s Placebo-Controlled Symptom Relief in ORBITA-2

Posted by MedXY By MedXY 04/22/2026
ORBITA-2 reveals PCI’s superior placebo-controlled angina relief in focal vs. diffuse coronary artery disease, with physiological disease patterns guiding treatment decisions.
Read More

Posts pagination

Previous page 1 … 10 11 12 13 14 … 59 Next page
  • Cardiac Resynchronization Therapy With or Without Defibrillator in Nonischemic Cardiomyopathy: Evidence Synthesis and Clinical Implications from DECIDE-CRT and Related Studies
  • Decoding the U-Shaped Relationship Between Left Ventricular Size and Mortality in Heart Failure Patients
  • Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation
  • Seven-Year Health Outcomes After TAVR Versus SAVR in Low-Risk Aortic Stenosis Patients: Insights from the PARTNER 3 Trial
  • Left Ventricular Hypertrabeculation in Dilated Cardiomyopathy: Prognostic Insights and Clinical Implications
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prostate cancer public health quality of life randomized clinical trial randomized controlled trial randomized trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in